Formulation and Process Optimization of Paclitaxel-loaded PLGA Nanoparticles

doi:10.7525/j.issn.1673-5102.2019.04.018

Abstract

Abstract: Paclitaxel-loaded PLGA nanoparticles(PTX-PLGA NPs) was prepared by emulsion solvent evaporation method with the biodegradable materials-poly(lactic-co-glycolic acid)(PLGA) used as carrier materials. The best formulation and preparation conditions were optimized by orthogonal test, investigating the influence of the ratio of paclitaxel and PLGA, the amount of surfactant, the amount of dichloromethane(DCM) and shearing rate on the preparation of nanoparticles. The optimal preparation conditions for PTX-PLGA NPs were as follows:the ratio of paclitaxel and PLGA of 4:1, the amount of surfactant of 0.1%, the amount of dichloromethane of 4 mL and shearing rate of 16 000 r·min^-1. With optimization of the formulation and preparation conditions, the PTX-PLGA NPs are regularly spherical in shape with the mean size of (207.1±20.5) nm, and the ζ-potential of the NPs is about (-23.8±2.5) mV. The encapsulation efficiency was estimated to be 14.45%±0.04%, respectively. The size distribution of PTX-PLGA NPs frozen dry powder was sustained stable character in 12 h. The results indicate that PTX-PLGA NPs were successfully prepared by modified solvent evaporation method, which could provide the experimental basis for the development of a new anti-tumor sustained-release formulation.

Key words: Paclitaxel, poly(lactic-co-glycolic acid), emulsion(O/W) solvent evaporation, process optimization

CLC Number:

Q949.66+1

WANG Si-Ying, ZHAO Xiu-Hua, ZHAO Dong-Mei. Formulation and Process Optimization of Paclitaxel-loaded PLGA Nanoparticles[J]. Bulletin of Botanical Research, 2019, 39(4): 627-633.

References

1. Sahoo S K,Labhasetwar V. Nanotech approaches to drug delivery and imaging[J]. Drug Discovery Today,2003,8(24):1112-1120.
2. 单常,祖元刚,赵修华,等. 叶酸偶联牛血清白蛋白负载卡铂和紫杉醇肿瘤靶向纳米粒制备、表征及体外释放性能评价[J]. 植物研究,2013,33(4):484-489.
Shan C,Zu Y G,Zhao X H,et al. Preparation,characterization and evaluation of in vitro release of folate-conjugated carboplatin and paclitaxel-loaded bovine serum albumin tumor-targeting nanoparticles[J]. Bulletin of Botanical Research,2013,33(4):484-489.
3. 张智舟,姜守刚,祖元刚,等. 多西紫杉醇白蛋白微球的制备及优化实验研究[J]. 植物研究,2011,31(3):381-384.
Zhang Z Z,Jiang S G,Zu Y G,et al. Preparation and optimization experiment of docetaxel-loaded bovine serum albumin nanoparticles[J]. Bulletin of Botanical Research,2011,31(3):381-384.
4. Labhasetwar V,Song C X,Levy R J. Nanoparticle drug delivery system for restenosis[J]. Advanced Drug Delivery Reviews,1997,24(1):63-85.
5. Astete C E,Sabliov C M. Synthesis and characterization of PLGA nanoparticles[J]. Journal of Biomaterials Science,Polymer Edition,2006,17(3):247-289.
6. Mu L,Feng S S. A novel controlled release formulation for the anticancer drug paclitaxel(Taxol^®):PLGA nanoparticles containing vitamin E TPGS[J]. Journal of Controlled Release,2003,86(1):33-48.
7. Feng S S,Zeng W T,Lim Y T,et al. Vitamin E TPGS-emulsified poly (lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment[J]. Nanomedicine,2007,2(3):333-344.
8. Sharma A,Mayhew E,Straubinger R M. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model[J]. Cancer Research,1993,53(24):5877-5881.
9. Ibrahim N K,Desai N,Legha S,et al. Phase I and pharmacokinetic study of ABI-007,a cremophor-free,protein-stabilized,nanoparticle formulation of paclitaxel[J]. Clinical Cancer Research,2002,8(5):1038-1044.
10. Sparreboom A,Scripture C D,Trieu V,et al. Comparative preclinical and clinical pharmacokinetics of a cremophor-free,nanoparticle albumin-bound paclitaxel(ABI-007) and paclitaxel formulated in cremophor (Taxol)[J]. Clinical Cancer Research,2005,11(11):4136-4143.
11. Dahmani F Z,Yang H,Zhou J P,et al. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles:preparation,in vitro and in vivo evaluation[J]. European Journal of Pharmaceutical Sciences,2012,47(1):179-189.
12. Li Y M,Bi Y L,Xi Y W,et al. Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles[J]. Journal of Drug Targeting,2013,21(2):188-199.
13. Zhao L Y,Feng S S. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers:in vitro and in vivo studies[J]. Journal of Pharmaceutical Sciences,2010,99(8):3552-3560.
14. Tosi G,Bortot B,Ruozi B,et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier[J]. Current Medicinal Chemistry,2013,20(17):2212-2225.
15. 李洁丽,郑春丽,刘建平,等. 多柔比星PLGA纳米粒的处方工艺优化及体外释药行为研究[J]. 药学学报,2013,48(5):759-766.
Li J L,Zheng C L,Liu J P,et al. Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release[J]. Acta Pharmaceutica Sinica,2013,48(5):759-766.
16. 寇龙发,高利芳,姚情,等. 乳化溶剂挥发法制备紫杉醇PLGA纳米粒及其体外评价[J]. 中国药剂学杂志,2014,12(2):33-42.
Kou L F,Gao L F,Yao Q,et al. Preparation and in vitro evaluation of paclitaxel loaded PLGA nanoparticles by emulsion-solvent evaporation method[J]. Chinese Journal of Pharmaceutics,2014,12(2):33-42.
17. Makino K,Nakajima T,Shikamura M,et al. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres:effects of molecular weight and composition of PLGA on release of rifampicin[J]. Colloids and Surfaces B:Biointerfaces,2004,36(1):35-42.
18. Hamishehkar H,Emami J,Najafabadi A R,et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid)microspheres prepared by a single phase oil in oil solvent evaporation method[J]. Colloids and Surfaces B:Biointerfaces,2009,74(1):340-349.
19. Sirsi S R,Schray R C,Wheatley M A,et al. Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol)copolymers complexed to oligonucleotides[J]. Journal of Nanobiotechnology,2009,7:1.
20. 何晋浙,姚丽娜,孙培龙. 响应面试验优化猴头菌素-PLGA微球制备工艺及其体外释药性能[J]. 食品科学,2017,38(6):242-247.
He J Z,Yao L N,Sun P L. Optimized preparation and in vitro release properties of Erinacines-PLGA microspheres by response surface methodology[J]. Food Science,2017,38(6):242-247.

[1]	LIU Pei-Yan, WANG Si-Ying, GUO Zi-Jing, ZHAO Xiu-Hua. Extraction Technology of Gutta-percha from Eucommia ulmoides Leaves Pretreated with Fungus and Dilute Alkali [J]. Bulletin of Botanical Research, 2019, 39(5): 788-794.
[2]	SHAN Chang;ZU Yuan-Gang*;ZHAO Xiu-Hua;SANG Mei. Preparation, Characterization and Evaluation of in vitro Release of Folate-Conjugated Carboplatin and Paclitaxel -loaded Bovine Serum Albumin Tumor-targeting Nanoparticles [J]. Bulletin of Botanical Research, 2013, 33(4): 484-489.
[3]	XU Chao;;JIANG Shou-Gang;;GONG Xian-Feng;ZU Yuan-Gang;*. Nano-paclitaxel Transport by Human Intestinal Epithelial Caco-2 Cells [J]. Bulletin of Botanical Research, 2013, 33(3): 339-345.
[4]	ZHANG Yu;JIANG Shou-Gang;ZU Yuan-Gang;WANG Zhuo;FU Yu-Jie. Optimization of Extration of 7-xylosyl-10-deacetylpaclitaxel from Taxus cuspidata* [J]. Bulletin of Botanical Research, 2010, 30(3): 369-372.
[5]	LI Shuang-Ming;SUN Rui;LUO Hao;SUN Su;WANG Ying;FU Yu-Jie. The Influence of UV Radiation on the Contents of Paclitaxel and Cephalomannine in the Fresh Leaves of Taxus cuspidata* [J]. , 2007, 27(4): 500-503.